Research To Practice (RTP) is pleased to offer community- and academic-based hospitals and cancer centers throughout the United States the opportunity to participate in an interactive live educational activity focused on the management of select B-cell lymphomas. Each session in this regional series will feature a blend of didactic presentation, discussion of steering committee members’ treatment recommendations, interactive polling of attendees using keypad devices and follow-up audience Q&A.
If you are interested in hosting a session at your institution, please email our Meeting Services Department at GRTeam@ResearchToPractice.com or call (800) 233-6153.
Schedule of Events
Monday, May 4, 2020 6:00 PM – 7:00 PM Education program Faculty Ann S LaCasce, MD, MMSc |
Suburban Hematology-Oncology Associates Lawrenceville, Georgia Buffet dinner will be provided |
Registration is open only to oncology professionals from this institution and invited guests. Email us for more information. |
Each 1-hour session will include 4 topic modules focused on current management, emerging research and novel agents and strategies under active investigation for select lymphomas and chronic lymphocytic leukemia. Each event will employ an identical format that will include the following elements:
Each session will conclude with a 5-minute Q&A segment
STEERING COMMITTEE MEMBERS
Target Audience
This activity is intended for medical oncologists and other healthcare providers involved in the treatment of select lymphomas and chronic lymphocytic leukemia.
Learning Objectives
CME Credit Form
A CME credit form will be given to each participant at the conclusion of the activity.
Accreditation Statement
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
Research To Practice designates each live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Policy
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess conflicts of interest with faculty, planners and managers of CME activities. Conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. Financial disclosures will be provided in meeting course materials.
Commercial Support
These activities are supported by educational grants from AbbVie Inc, Gilead Sciences Inc, Novartis, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC, and Seattle Genetics.